Improved Care for Patients with Moderate-to-Severe Asthma: Reflecting on Errors and Missed Opportunities

Activity Overview

The goal of this activity is to foster recognition of missed opportunities and suboptimal care among patients with moderate-to-severe asthma, thereby helping clinicians who treat these patients to examine best practices for management.

0.50 CE Credit(s)
Expires: December 30, 2020

Target Audience

The target audience for this activity is allergy/immunology and pulmonology physicians practicing outside of the United States, who manage patients with moderate-to-severe asthma.

Learning Objectives

Upon successful completion of this education activity, participants should be better able to:

  • Distinguish between the different types of asthma based on underlying pathophysiology and biomarkers of disease in order to make personalized treatment decisions
  • Identify patients with poorly-controlled or difficult-to-treat asthma who are eligible for step-up therapies, including new and emerging biologics
  • Incorporate new and emerging targeted biologics into the management of patients with severe or poorly-controlled asthma, when appropriate

Activity Faculty

Ratko Djukanovic, MD, DM, FRCP

Ratko Djukanovic, MD, DM, FRCP (Chair)

Professor, Medicine
Director, Southampton NIHR Respiratory Biomedical Research Unit
Director, NIHR Southampton Centre for Biomedical Research
Southampton, UK

Stephen P. Peters, MD, PhD, FAAAAI, FACP, FCCP, FCPP

Stephen P. Peters, MD, PhD, FAAAAI, FACP, FCCP, FCPP

Thomas H. Davis Chair, Pulmonary Medicine
Chief, Section on Pulmonary, Critical Care, Allergy & Immunologic Diseases
Professor, Internal Medicine, Pediatrics and Translational Science
Wake Forest Baptist Health
Winston-Salem, NC

Michael E. Wechsler, MD, MMSc

Michael E. Wechsler, MD, MMSc

Co-Director, The Cohen Family Asthma Institute
Professor, Department of Medicine
National Jewish Health
Denver, CO